Wedbush Reiterates Outperform Rating on Jade Biosciences (JBIO)

October 1, 2026 2:28 AM EDT Send to a Friend
Wedbush analyst Laura Chico reiterated an Outperform rating and $47.00 price target on Jade Biosciences (NASDAQ: JBIO)The analyst comments: “The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login